Sorin 3T Heater-Cooler System (No. II)

The Sorin 3T Heater-Cooler docket is a device-injury matter now well into its tail: claims allege that a cardiac-surgery heater-cooler unit harbored nontuberculous mycobacteria that contaminated the surgical field during open-heart procedures, producing serious post-surgical infections in patients who had no reason to expect an infection risk from equipment used to regulate blood temperature during bypass. With only a handful of actions still pending years after centralization, this is a docket where most of the claim population has already moved through resolution, and what remains is a small number of individual files rather than a broad inventory.

That changes the funding calculus. Rather than portfolio-level financing against a large, homogeneous claim pool, capital here is more likely to be evaluated claim-by-claim, weighing the strength of an individual plaintiff's causation record — culture-confirmed infection, exposure timeline, surgical records — against the value of a prolonged, invasive-infection injury. These are medically serious claims, often involving extended hospitalization, revision surgery, or long-term antimicrobial treatment, so medical-lien exposure can be meaningful and should be sized early: hospital, Medicare, and Medicare Advantage liens on a cardiac-surgery-and-infection claim can represent a substantial share of gross recovery before a funding structure is even priced.

For a firm or claimant holding one of the remaining files, timing is also shaped by how far the broader docket has already moved toward resolution — a late-stage MDL with a shrinking active docket generally offers more pricing information than an early one, even without a public settlement program, because comparable claims have already been tested. Criterica Capital's mass tort finance product is structured for this kind of device-injury claim, sizing advances against the underlying medical and liability record rather than against a docket-wide average.

A structural read on where this litigation stands, and how it compares to other cardiac-device dockets, from Criterica Intelligence can help frame expectations before pricing any individual file in this docket.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.